ISPE 2026 Pharma 4.0™与生物制药大会：INOSIM与Octapharma将分享全生命周期整体数字孪生应用
Pharma 4.0™ in Action: How Holistic Digital Twins Are Transforming Biopharma Manufacturing
ISPE 2026 Pharma 4.0™与生物制药大会将于12月10-11日在柏林及线上举行，INOSIM的Peer Sander与Octapharma的Dennis Meister将分享"整体数字孪生"专题。该专题介绍将仿真从工程设计阶段延伸至日常生产运营的数字孪生方法，用于优化设施设计、生产计划与资源利用，并更早识别瓶颈及GMP相关偏差。
These challenges will be at the center of discussion during the 2026 ISPE Pharma 4.0™ and Biopharma Conference, taking place 10-11 December in Berlin, Germany, and virtually. Bringing together industry leaders, technology experts, and manufacturing professionals, the conference will showcase practical applications of digital transformation across the pharmaceutical lifecycle.
Among the featured sessions is "Pharma 4.0™ in Engineering and Operations: Holistic Digital Twins," presented by Peer Sander, INOSIM GmbH, and Dennis Meister, Octapharma. The session, which is part of the Pharma 4.0™ in Action: Biopharma Manufacturing Transformation track, will explore how digital twin technology is helping manufacturers optimize facility design, improve operational performance, and generate measurable business value across the entire plant lifecycle.
Addressing Modern Manufacturing Challenges
Today's pharmaceutical facilities are more complex than ever before. Manufacturers must balance increasing demand for medicines with strict regulatory expectations, evolving production technologies, and the need to remain cost competitive in a global marketplace.
According to Peer Sander, pharmaceutical manufacturers are experiencing growing pressure to achieve more efficient and optimized production while continuing to meet stringent quality and compliance requirements. At the same time, the high value of pharmaceutical products makes operational reliability and process robustness critical business priorities.
Successfully balancing these objectives can be particularly challenging in modern facilities, where interconnected processes, sophisticated equipment, and complex workflows create new operational demands. As a result, many organizations are looking beyond isolated digital tools and pursuing fully integrated Pharma 4.0™ strategies that connect engineering, manufacturing, and operational decision-making.
The session will demonstrate how digital twins are helping bridge this gap.
Moving Beyond Simulation
Simulation has long been used to support facility design and process optimization. Traditionally, however, these models have been utilized primarily during project planning phases and then set aside once facilities become operational.
The approach presented by Octapharma and INOSIM extends simulation far beyond the design stage.
As Sander explains, the organizations have developed a methodology that combines production performance, efficiency, and operational robustness through advanced production simulation. What makes the approach particularly noteworthy is that simulation is not limited to offline engineering activities. Instead, simulation models are brought into day-to-day operations, creating a true digital twin application that continuously supports manufacturing execution and decision-making.
This evolution represents an important step in the practical implementation of Pharma 4.0™ principles. By creating a dynamic digital representation of manufacturing operations, organizations can gain greater visibility into plant performance, evaluate potential outcomes before making decisions, and proactively identify opportunities for improvement.
Rather than relying solely on retrospective analysis, manufacturers can use digital twins to support real-time operational awareness and more informed decision-making.
Creating Value Across the Plant Lifecycle
One of the key themes of the session is the value that digital twins can deliver throughout the entire facility lifecycle.
The journey often begins during engineering and capital project phases, where sophisticated simulation models can be used to evaluate facility designs, production strategies, and capacity requirements before construction or implementation decisions are finalized.
This approach enables companies to identify potential constraints earlier, evaluate alternative scenarios, and develop more efficient facility concepts. The result can be manufacturing systems that achieve higher performance while helping minimize capital expenditures.
However, the benefits do not end once a facility begins operating.
The session will highlight how Octapharma has expanded the use of simulation into live production environments, allowing teams to continuously optimize manufacturing performance. This operational digital twin approach supports improved planning, more efficient resource utilization, and enhanced visibility into production activities.
By connecting simulation models with real-world operational data, manufacturers can establish a powerful framework for continuous improvement.
Supporting Smarter Operational Decisions
As facilities become increasingly data-rich, one of the greatest opportunities lies in turning information into actionable insights.
According to Sander, operational digital twins can help organizations continuously improve production planning while enabling the real-time identification and avoidance of delays, bottlenecks, and GMP-relevant deviations. These capabilities allow manufacturing teams to address issues proactively rather than reactively, reducing disruptions and supporting more predictable operations.
The ability to evaluate alternative scenarios before implementing changes also provides a valuable advantage. Manufacturers can assess the potential impact of scheduling decisions, equipment availability, resource constraints, and process changes in a virtual environment before making adjustments on the plant floor.
This enhanced visibility supports more effective decision-making while helping maintain the quality and compliance standards expected in pharmaceutical manufacturing.
Attendees will gain insight into how these capabilities translate into tangible operational improvements, including:
- Improved production planning and scheduling
- Enhanced resource and asset utilization
- Earlier identification of bottlenecks and operational constraints
- Reduced risk of delays and GMP-relevant deviations
- Greater operational transparency
- Data-driven decision-making across manufacturing activities
- Increased throughput while maintaining robust and reliable operations
A Practical Example of Pharma 4.0™ in Action
While discussions surrounding Industry 4.0 and Pharma 4.0™ often focus on future possibilities, this session emphasizes real-world implementation.
Through practical examples and case studies, Sander and Meister will demonstrate how digital transformation initiatives can move beyond strategy and deliver measurable business outcomes. Attendees will learn how a holistic approach to digital twins can create value from early engineering design through ongoing production operations.
The presentation also highlights an important shift occurring across the industry. Rather than viewing digital technologies as standalone projects, leading organizations are increasingly integrating them into broader operational frameworks that support long-term business objectives.
For companies seeking to strengthen competitiveness, improve operational excellence, and build more resilient manufacturing systems, these lessons offer valuable insights into what successful Pharma 4.0™ implementation looks like in practice.
Join the Conversation in Berlin
The 2026 ISPE Pharma 4.0™ and Biopharma Conference will provide a unique opportunity to explore how digital technologies, advanced manufacturing strategies, and data-driven decision-making are shaping the future of pharmaceutical operations.
The session reflects one of the central themes of the 2026 ISPE Pharma 4.0™ and Biopharma Conference: moving beyond digital transformation concepts to real-world implementation. By sharing practical experiences and measurable outcomes, Sander and Meister will demonstrate how digital twin technologies are helping biopharmaceutical manufacturers improve efficiency, robustness, and competitiveness in an increasingly complex operating environment.
For professionals involved in engineering, manufacturing, digital transformation, operations, quality, and technology implementation, this session will provide valuable insights into how digital twins are driving measurable improvements in efficiency, performance, and operational robustness.
来源：ISPE iSpeak 专家博客 · ispe.org